Nautilus Biotechnolgy
NAUT
NAUT
86 hedge funds and large institutions have $120M invested in Nautilus Biotechnolgy in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
23% less capital invested
Capital invested by funds: $155M → $120M (-$35M)
Holders
86
Holding in Top 10
4
Calls
$9K
Puts
–
Top Buyers
| 1 | +$378K | |
| 2 | +$264K | |
| 3 | +$153K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$91K |
| 5 |
SGM
Skye Global Management
West Palm Beach,
Florida
|
+$68.8K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$672K | |
| 3 | -$544K | |
| 4 |
Millennium Management
New York
|
-$303K |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$274K |